210 related articles for article (PubMed ID: 25577339)
1. Human-derived cathelicidin LL-37 directly activates mast cells to proinflammatory mediator synthesis and migratory response.
Bąbolewska E; Brzezińska-Błaszczyk E
Cell Immunol; 2015 Feb; 293(2):67-73. PubMed ID: 25577339
[TBL] [Abstract][Full Text] [Related]
2. Cathelicidin rCRAMP stimulates rat mast cells to generate cysteinyl leukotrienes, synthesize TNF and migrate: involvement of PLC/A2, PI3K and MAPK signaling pathways.
Bąbolewska E; Pietrzak A; Brzezińska-Błaszczyk E
Int Immunol; 2014 Nov; 26(11):637-46. PubMed ID: 24990383
[TBL] [Abstract][Full Text] [Related]
3. Antimicrobial peptides human beta-defensins and cathelicidin LL-37 induce the secretion of a pruritogenic cytokine IL-31 by human mast cells.
Niyonsaba F; Ushio H; Hara M; Yokoi H; Tominaga M; Takamori K; Kajiwara N; Saito H; Nagaoka I; Ogawa H; Okumura K
J Immunol; 2010 Apr; 184(7):3526-34. PubMed ID: 20190140
[TBL] [Abstract][Full Text] [Related]
4. The antimicrobial peptide LL-37 induces synthesis and release of cysteinyl leukotrienes from human eosinophils--implications for asthma.
Sun J; Dahlén B; Agerberth B; Haeggström JZ
Allergy; 2013 Mar; 68(3):304-11. PubMed ID: 23330796
[TBL] [Abstract][Full Text] [Related]
5. A cathelicidin family of human antibacterial peptide LL-37 induces mast cell chemotaxis.
Niyonsaba F; Iwabuchi K; Someya A; Hirata M; Matsuda H; Ogawa H; Nagaoka I
Immunology; 2002 May; 106(1):20-6. PubMed ID: 11972628
[TBL] [Abstract][Full Text] [Related]
6. Human cathelicidin CAP18/LL-37 changes mast cell function toward innate immunity.
Yoshioka M; Fukuishi N; Kubo Y; Yamanobe H; Ohsaki K; Kawasoe Y; Murata M; Ishizumi A; Nishii Y; Matsui N; Akagi M
Biol Pharm Bull; 2008 Feb; 31(2):212-6. PubMed ID: 18239275
[TBL] [Abstract][Full Text] [Related]
7. The modulatory effect of TLR2 on LL-37-induced human mast cells activation.
Zhang YY; Yu YY; Zhang YR; Zhang W; Yu B
Biochem Biophys Res Commun; 2016 Feb; 470(2):368-374. PubMed ID: 26778002
[TBL] [Abstract][Full Text] [Related]
8. Innate defense regulator IDR-1018 activates human mast cells through G protein-, phospholipase C-, MAPK- and NF-ĸB-sensitive pathways.
Yanashima K; Chieosilapatham P; Yoshimoto E; Okumura K; Ogawa H; Niyonsaba F
Immunol Res; 2017 Aug; 65(4):920-931. PubMed ID: 28653285
[TBL] [Abstract][Full Text] [Related]
9. The cathelicidin LL-37 activates human mast cells and is degraded by mast cell tryptase: counter-regulation by CXCL4.
Schiemann F; Brandt E; Gross R; Lindner B; Mittelstädt J; Sommerhoff CP; Schulmistrat J; Petersen F
J Immunol; 2009 Aug; 183(4):2223-31. PubMed ID: 19625657
[TBL] [Abstract][Full Text] [Related]
10. Group A
Clark M; Kim J; Etesami N; Shimamoto J; Whalen RV; Martin G; Okumura CYM
Front Immunol; 2018; 9():327. PubMed ID: 29535718
[TBL] [Abstract][Full Text] [Related]
11. LL-37-induced human mast cell activation through G protein-coupled receptor MrgX2.
Yu Y; Zhang Y; Zhang Y; Lai Y; Chen W; Xiao Z; Zhang W; Jin M; Yu B
Int Immunopharmacol; 2017 Aug; 49():6-12. PubMed ID: 28549244
[TBL] [Abstract][Full Text] [Related]
12. Human cathelicidin LL-37 and its derivative IG-19 regulate interleukin-32-induced inflammation.
Choi KY; Napper S; Mookherjee N
Immunology; 2014 Sep; 143(1):68-80. PubMed ID: 24666281
[TBL] [Abstract][Full Text] [Related]
13. Lipoteichoic acids selectively stimulate rat mast cells to cysteinyl leukotriene generation and affect mast cell migration after tumor necrosis factor (TNF)-priming.
Brzezińska-Błaszczyk E; Rdzany RS
Immunol Lett; 2007 Apr; 109(2):138-44. PubMed ID: 17350692
[TBL] [Abstract][Full Text] [Related]
14. Mas-related gene X2 (MrgX2) is a novel G protein-coupled receptor for the antimicrobial peptide LL-37 in human mast cells: resistance to receptor phosphorylation, desensitization, and internalization.
Subramanian H; Gupta K; Guo Q; Price R; Ali H
J Biol Chem; 2011 Dec; 286(52):44739-49. PubMed ID: 22069323
[TBL] [Abstract][Full Text] [Related]
15. Botulinum toxin blocks mast cells and prevents rosacea like inflammation.
Choi JE; Werbel T; Wang Z; Wu CC; Yaksh TL; Di Nardo A
J Dermatol Sci; 2019 Jan; 93(1):58-64. PubMed ID: 30658871
[TBL] [Abstract][Full Text] [Related]
16. Modulation of host defense peptide-mediated human mast cell activation by LPS.
Gupta K; Subramanian H; Ali H
Innate Immun; 2016 Jan; 22(1):21-30. PubMed ID: 26511058
[TBL] [Abstract][Full Text] [Related]
17. Differential Regulation of Mas-Related G Protein-Coupled Receptor X2-Mediated Mast Cell Degranulation by Antimicrobial Host Defense Peptides and Porphyromonas gingivalis Lipopolysaccharide.
Gupta K; Idahosa C; Roy S; Lee D; Subramanian H; Dhingra A; Boesze-Battaglia K; Korostoff J; Ali H
Infect Immun; 2017 Oct; 85(10):. PubMed ID: 28694291
[No Abstract] [Full Text] [Related]
18. Pleurocidin, a novel antimicrobial peptide, induces human mast cell activation through the FPRL1 receptor.
Pundir P; Catalli A; Leggiadro C; Douglas SE; Kulka M
Mucosal Immunol; 2014 Jan; 7(1):177-87. PubMed ID: 23839065
[TBL] [Abstract][Full Text] [Related]
19. Epithelial cell-derived antibacterial peptides human beta-defensins and cathelicidin: multifunctional activities on mast cells.
Niyonsaba F; Hirata M; Ogawa H; Nagaoka I
Curr Drug Targets Inflamm Allergy; 2003 Sep; 2(3):224-31. PubMed ID: 14561157
[TBL] [Abstract][Full Text] [Related]
20. Skin mast cells protect mice against vaccinia virus by triggering mast cell receptor S1PR2 and releasing antimicrobial peptides.
Wang Z; Lai Y; Bernard JJ; Macleod DT; Cogen AL; Moss B; Di Nardo A
J Immunol; 2012 Jan; 188(1):345-57. PubMed ID: 22140255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
